Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rheumatoid arthritis
rheumatoid arthritis
Tocilizumab Approval Causes Buzz
Elsevier Global Medical News
Tue, 01/12/10 - 09:59 am
tocilizumab
Roche
FDA
rheumatoid arthritis
Lilly inks licensing deal for Incyte drug
Marketwatch
Mon, 12/21/09 - 09:28 am
Incyte
Eli Lilly
liscensing
rheumatoid arthritis
Roche Should Give More Data on RoActemra Drug, U.K.’s NICE Says
Bloomberg
Wed, 12/16/09 - 10:10 am
Roche
rheumatoid arthritis
UK
RoActemra
Encouraging Data on J&J's Simponi
Yahoo/Zacks.com
Mon, 11/23/09 - 10:10 am
Simponi
rheumatoid arthritis
JNJ
Bristol-Myers Squibb signs development deal for rheumatoid arthritis drug with Alder Biopharma
Yahoo/AP
Tue, 11/10/09 - 09:00 am
Alder Biopharma
Bristol-Myers Squibb
rheumatoid arthritis
UK trust sues Amgen, Wyeth over Enbrel patent
Reuters
Thu, 10/29/09 - 05:42 am
Amgen
Wyeth
lawsuits
Enbrel
patents
UK
rheumatoid arthritis
Genentech and Biogen Idec Receive a Complete Response from FDA for Earlier Use of Rituxan for Rheumatoid Arthritis
Businesswire
Mon, 10/19/09 - 07:46 am
Rituxan
rheumatoid arthritis
Roche
Genentech
FDA
Phase III Study Showed Two Years of ACTEMRA® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission
Reuters
Sun, 10/18/09 - 10:58 am
Actemra
tocilizumab
rheumatoid arthritis
Genentech
CP-690,550, Pfizer's Oral JAK Inhibitor, Demonstrates Response Both Alone And In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis
Yahoo/BusinessWire
Sun, 10/18/09 - 10:54 am
Pfizer
rheumatoid arthritis
Plexxikon Treats Initial Patient with First-in-Class Drug in Phase 1 Trial
Pipeline Review
Sat, 10/10/09 - 12:06 pm
Plexxikon
cancer
rheumatoid arthritis
ZymoGenetics’ rheumatoid arthritis drug test goes poorly
Bizjournals.com
Fri, 09/11/09 - 08:51 am
ZymoGenetics
rheumatoid arthritis
atacicept
Merck Serono
Another Positive Indication for Amgen's Denosumab
Seeking Alpha
Fri, 09/11/09 - 06:03 am
Amgen
denosumab
Novartis
rheumatoid arthritis
Adeona Prepares Three Drugs for NDA Submission
Offical Wire
Fri, 09/4/09 - 07:46 am
NDA
FDA
Adeona
Trimesta
MS
Zinthionein
macular degeneration
JP1
rheumatoid arthritis
Bristol-Myers says FDA broadens label for Orencia
Yahoo/AP
Wed, 08/26/09 - 10:19 am
FDA
Bristol-Myers Squibb
Orencia
rheumatoid arthritis
Rigel Pharma: The Importance of Knowing Your Stock
Seeking Alpha
Wed, 07/29/09 - 08:37 am
Rigel
rheumatoid arthritis
Rigel skids on rheumatoid arthritis drug failure
Yahoo/AP
Sat, 07/25/09 - 11:15 am
Rigel
rheumatoid arthritis
Rigel reports positive results from R788 study
Marketwatch
Thu, 07/9/09 - 08:29 am
Rigel
drug trials
rheumatoid arthritis
R788
New RA Data Could Be Magic Pill for Rigel
TheStreet.com
Mon, 06/15/09 - 11:10 am
rheumatoid arthritis
Rigel
R788
Pfizer rheumatoid arthritis drug meets study goals
Yahoo/AP
Fri, 06/12/09 - 08:03 am
Pfizer
rheumatoid arthritis
drug trials
Roche set to unveil new rheumatism drug
Hays Pharma, UK
Fri, 06/5/09 - 09:34 am
Roche
rheumatoid arthritis
Actemra
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
next ›
last »